MX2023005315A - Pelicula delgada oral. - Google Patents

Pelicula delgada oral.

Info

Publication number
MX2023005315A
MX2023005315A MX2023005315A MX2023005315A MX2023005315A MX 2023005315 A MX2023005315 A MX 2023005315A MX 2023005315 A MX2023005315 A MX 2023005315A MX 2023005315 A MX2023005315 A MX 2023005315A MX 2023005315 A MX2023005315 A MX 2023005315A
Authority
MX
Mexico
Prior art keywords
thin film
oral thin
polyvinyl alcohol
matrix layer
oral
Prior art date
Application number
MX2023005315A
Other languages
English (en)
Inventor
Markus Müller
Michael Linn
Florian Hammes
Mario Ficker
Original Assignee
Lts Lohmann Therapie Systeme Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE102021120937.4A external-priority patent/DE102021120937A1/de
Application filed by Lts Lohmann Therapie Systeme Ag filed Critical Lts Lohmann Therapie Systeme Ag
Publication of MX2023005315A publication Critical patent/MX2023005315A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Laminated Bodies (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Se describe una película delgada oral que comprende por lo menos una capa de matriz, en donde la al menos una capa de matriz comprende por lo menos un agente farmacéuticamente activo, por lo menos un alcohol polivinílico y por lo menos un copolímero de injerto de alcohol polivinílico-polietilenglicol; un método para producirlo; y el uso de éste como medicamento.
MX2023005315A 2020-11-09 2021-11-05 Pelicula delgada oral. MX2023005315A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102020129394 2020-11-09
DE102021120937.4A DE102021120937A1 (de) 2021-08-11 2021-08-11 Oraler Dünnfilm
PCT/EP2021/080825 WO2022096676A1 (en) 2020-11-09 2021-11-05 Oral thin film

Publications (1)

Publication Number Publication Date
MX2023005315A true MX2023005315A (es) 2023-05-25

Family

ID=78536076

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023005315A MX2023005315A (es) 2020-11-09 2021-11-05 Pelicula delgada oral.

Country Status (10)

Country Link
US (3) US20230404914A1 (es)
EP (2) EP4240336A1 (es)
JP (2) JP2023548215A (es)
KR (1) KR20230106658A (es)
CN (1) CN114452269A (es)
AU (1) AU2021374831A1 (es)
CA (1) CA3198970A1 (es)
MX (1) MX2023005315A (es)
PL (1) PL3995137T3 (es)
WO (1) WO2022096676A1 (es)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005058569B4 (de) * 2005-12-08 2010-07-15 Lts Lohmann Therapie-Systeme Ag Schaumwafer mit Polyvinylalkohol-Polyethylenglycol-Pfropfcopolymer
WO2014020155A1 (en) * 2012-08-02 2014-02-06 Clinpharm Reform Gmbh Oral transmucosal adminstration forms of s-ketamine
US11207316B2 (en) * 2014-05-30 2021-12-28 West Virginia University Ketamine or dextromethorphan formulations and methods of use
CN105343887B (zh) * 2015-10-30 2018-04-27 济南康和医药科技有限公司 一种右佐匹克隆口腔速溶膜及其制备方法
DE102017112527B4 (de) * 2017-06-07 2019-01-03 Lts Lohmann Therapie-Systeme Ag Schnell zerfallende Schaumwafer mit hohem Flächengewicht
US11185500B2 (en) * 2017-06-18 2021-11-30 Oak Therapeutics Inc. Multi-layered high dosage dissolvable film for oral administration
DE102017129012A1 (de) * 2017-12-06 2019-06-06 Lts Lohmann Therapie-Systeme Ag Oraler Dünnfilm mit hoher Wirkstoffbeladung
DE102018109981A1 (de) * 2018-04-25 2019-10-31 Lts Lohmann Therapie-Systeme Ag U-förmiger oraler Dünnfilm
AU2019302664B2 (en) * 2018-07-11 2022-11-17 Cure Pharmaceutical, Inc. Rapidly disintegrating oral film matrix
AU2020234029A1 (en) * 2019-03-14 2021-09-16 Esocap Ag Pharmaceutical dosage form for application to mucous membranes and methods for producing same

Also Published As

Publication number Publication date
AU2021374831A1 (en) 2023-06-29
EP3995137B1 (de) 2024-01-03
KR20230106658A (ko) 2023-07-13
WO2022096676A8 (en) 2023-05-19
CA3198970A1 (en) 2022-05-12
US20230404914A1 (en) 2023-12-21
WO2022096676A1 (en) 2022-05-12
US20230165805A1 (en) 2023-06-01
EP3995137A1 (de) 2022-05-11
PL3995137T3 (pl) 2024-05-06
CN114452269A (zh) 2022-05-10
JP2022076476A (ja) 2022-05-19
US11992561B2 (en) 2024-05-28
JP7217794B2 (ja) 2023-02-03
JP2023548215A (ja) 2023-11-15
EP4240336A1 (en) 2023-09-13
US20220160646A1 (en) 2022-05-26

Similar Documents

Publication Publication Date Title
CL2008002406A1 (es) Composicion de pelicula de disolucion oral que comprende un agente activo cosmetico o farmaceutico, y un copolimero de injerto de poli(alcohol de vinilo)-polietilenglicol (divisional de la solicitud 1825-04).
CO6321222A2 (es) Una forma de dosificacion unitaria que comprende una matriz de pelicula delgada soluble en agua (oblea) que contiene un ingrediente activo
ATE269709T1 (de) Tablette mit verzögerter freigabe enthaltend einen blutzuckersenkenden wirkstoff und einen antihyperglyzemischen wirkstoff
PT1631255E (pt) Sistema de administração de fármacos
ES2180251T3 (es) Comprimido revestido con polimero, que contiene amoxicilina y clavulanato.
DK0732922T3 (da) Transdermal afgivelsesindretning
RS54929B1 (sr) Formulacija i metod obložene tablete
WO2017180967A3 (en) Multilayer thin film device encapsulation using soft and pliable layer first
DE502004005154D1 (de) Multipartikuläre arzneiform, enthaltend mucoadhaesiv formulierte peptid- oder protein-wirkstoffe, sowie ein verfahren zur herstellung der arzneiform
NO891680L (no) Osmotisk kontinuerlig avgivende oralt avgivelsessystem inneholdende et farmasoeytisk akseptabelt aktivt middel som har forbedrede kjernemembran-adhesjonsegenskaper.
ATE515949T1 (de) Süssware
CL2007002000A1 (es) Preparacion farmaceutica para la administracion oral con liberacion controlada de ingrediente activo en el intestino delgado que comprende portadores inertes, ingredientes activo, una capa interna compuesta de 2 capas de difusion para controlar la liberacion y una capa gastrorresistente; metodo de preparacion.
TW200635617A (en) Multiparticulate pharmaceutical form comprising mucoadhesively formulated nucleic acid active ingredients, and a process for producing the pharmaceutical form
MY161056A (en) Dental strip for administration of oral treatment
BR112022010435A2 (pt) Camada-suporte solúvel para filme fino oral (otf)
MX2023005315A (es) Pelicula delgada oral.
WO2002030402A3 (en) Film for active ingredients dermal and transdermal administration
UA102680C2 (ru) Единичная дозированная форма, которая включает привитый сополимер поливинилового спирта-полиэтиленгликоля и стероидный эстроген
AU2003301263A1 (en) Three layer tear formulation
MX2023008402A (es) Pelicula delgada oral multicapa.
ATE213933T1 (de) Orale zubereitung, enthaltend in einer in wässrigem medium quellbaren matrix wenigstens einen pharmazeutischen wirkstoff
WO2022060817A3 (en) Oral drug delivery device with expanding arms
MX2023008400A (es) Pelicula delgada oral de multiples capas.
MX2023008407A (es) Pelicula delgada oral que comprende una capa de regulador de ph de pva-tris (alcohol polivinilico-tris(hidroximetil)aminometano).
AR118580A1 (es) Formulación de tableta vaginal